The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FRESCO-2: A global phase III study of the efficacy and safety of fruquintinib in patients (pts) with metastatic colorectal cancer (mCRC).
 
Arvind Dasari
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen; Lexicon; Novartis; Voluntis
Research Funding - Eisai; Guardant Health; Hutchison MediPharma; Ipsen; Merck; Novartis
 
James C. Yao
Consulting or Advisory Role - Advanced Accelerator Applications; Chiasma; Crinetics Pharmaceuticals; Hutchison MediPharma; Merck; Nektar; Novartis/Ipsen
Research Funding - Novartis
 
Alberto F. Sobrero
Stock and Other Ownership Interests - Bayer
Consulting or Advisory Role - Amgen; Bayer; Celgene; Menarini; Merck Serono; Roche; Sanofi; SERVIER
Speakers' Bureau - amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; celgene; Lilly; Merck Serono; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche; Takeda
 
Takayuki Yoshino
Research Funding - Amgen (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); MSD (Inst); Ono Pharmaceutical (Inst); PAREXEL International Inc. (Inst); Sanofi (Inst); Sumitomo Dainippon (Inst); Taiho Pharmaceutical (Inst)
 
William R. Schelman
Employment - Hutchison MediPharma; Lilly
Stock and Other Ownership Interests - Hutchison China Meditech; Lilly
 
Shivani Nanda
Employment - Bayer; Hutchison MediPharma
Stock and Other Ownership Interests - Bayer; Hutchison MediPharma
 
Caly Chien
Employment - Hutchison MediPharma; Janssen Research & Development (I)
Stock and Other Ownership Interests - Hutchison China Meditech; Johnson & Johnson
 
Su-Fen Pu
Employment - Hutchison MediPharma; Merck
Stock and Other Ownership Interests - Merck
 
Marek K. Kania
Employment - Hutchison MediPharma
Leadership - Hutchison MediPharma
Stock and Other Ownership Interests - Hutchison MediPharma
 
Josep Tabernero
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bayer; BeiGene; Biocartis; Boehringer Ingelheim; Chugai Pharma; Foundation Medicine; Genentech; Genmab; HalioDx; Halozyme; Imugene; Inflection Biosciences; Ipsen; Kura Oncology; Lilly; Menarini; Merck Serono; Merrimack; Merus; Molecular Partners; MSD; Novartis; Peptomyc; Pfizer; Pharmacyclics; ProteoDesign; Rafael Pharmaceuticals; Roche; Roche; Sanofi; Seagen; Seagen; Servier; Symphogen; Taiho Pharmaceutical; VCN Biosciences
 
Cathy Eng
Consulting or Advisory Role - Array BioPharma; Bayer Schering Pharma; Foundation Medicine; Natera